Fondaparinux

Category: Blood Thinner (Anticoagulant)

Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by GlaxoSmithKline. A generic version developed by Alchemia is marketed within the US by Dr. Reddy's Laboratories. Contents 1 Medical uses 1.1 Comparison to other agents 2 Pharmacology 2.1 Mechanism of action 3 Chemistry 3.1 Abbreviations 4 References 5 External links Medical uses Clinically, it is used for the prevention of deep vein thrombosis ... [wikipedia]

Dosage List

Fondaparinux Sodium 2.5 mg/.5ml Subcutaneous Injection
NDC: 0781-3443
Labeler:
Sandoz Inc.
Fondaparinux Sodium 5 mg/.4ml Subcutaneous Injection
NDC: 0781-3454
Labeler:
Sandoz Inc.
Fondaparinux Sodium 7.5 mg/.6ml Subcutaneous Injection
NDC: 0781-3465
Labeler:
Sandoz Inc.
Fondaparinux Sodium 10 mg/.8ml Subcutaneous Injection
NDC: 0781-3476
Labeler:
Sandoz Inc.
Fondaparinux Sodium 2.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 11797-154
Labeler:
Italfarmaco S.p.a
Fondaparinux Sodium 5 mg/.4ml Subcutaneous Injection, Solution
NDC: 11797-155
Labeler:
Italfarmaco S.p.a
Fondaparinux Sodium 7.5 mg/.6ml Subcutaneous Injection, Solution
NDC: 11797-156
Labeler:
Italfarmaco S.p.a
Fondaparinux Sodium 10 mg/.8ml Subcutaneous Injection, Solution
NDC: 11797-157
Labeler:
Italfarmaco S.p.a
Fondaparinux Sodium 10 mg/.8ml Subcutaneous Injection
NDC: 43598-606
Labeler:
Dr. Reddy's Laboratories Inc.
Fondaparinux Sodium 2.5 mg/.5ml Subcutaneous Injection
NDC: 43598-607
Labeler:
Dr. Reddy's Laboratories Inc.

Related Brands

Drugs with the same active ingredients